Head-to-head · WeighScore
Dr. Arevitalize vs Wisp
The verdict
Dr. Arevitalize takes it — 65.2/100 to 64.4/100, but only just.
Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide fr Wisp is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Dr. Arevitalize | Wisp |
|---|---|---|
| WeighScore | 65.2/100 | 64.4/100 |
| Grade | C | C |
| Scorecard rank | #225 | #243 |
| Semaglutide | $319/mo (compounded) | $225/mo (compounded oral) |
| Tirzepatide | $359/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Graded #225 · C
Strengths
- Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
- Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
- LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
- Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)
Where it loses points
- Compounded GLP-1s are not FDA-approved finished products
- Compounding pharmacy partner and prescribing clinician are not named on the site
- State availability is not published on the site
Graded #243 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
- Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.